Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer
Clinical trial NCT01575782 · TERMINATED
Trial details
- NCT number
- NCT01575782
- Sponsor
- Maastricht Radiation Oncology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.